US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.430
  • -0.070-4.67%
Close Apr 25 16:00 ET
42.40MMarket Cap-760P/E (TTM)

About Immuneering Company

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolIMRX
Company NameImmuneering
Listing DateJul 30, 2021
Issue Price15.00
Founded2008
CEODr. Benjamin J. Zeskind, PhD
MarketNASDAQ
Employees68
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address245 Main Street,2nd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-500-8080
Websitehttp://www.immuneering.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Benjamin J. Zeskind, PhD
  • President, Chief Executive Officer and Director
  • 1.92M
  • Michael D. Bookman
  • Chief Legal Officer and Secretary
  • --
  • Mallory Morales
  • Chief Accounting Officer, Principal Financial Officer and Treasurer
  • --
  • Leah R. Neufeld
  • Chief People Officer
  • --
  • Dr. Brett Hall, PhD
  • Chief Scientific Officer
  • 1.40M
  • Harold Eugene Brakewood
  • Chief Business Officer
  • 1.47M
  • Ann E. Berman
  • Chairman of the Board and Lead Independent Director
  • 181.38K
  • Dr. Thomas J. Schall, PhD
  • Director
  • --
  • Dr. Diana F. Hausman, M.D.
  • Independent Director
  • 175.38K
  • Robert J. Carpenter
  • Independent Director
  • 202.74K
  • Peter Feinberg
  • Independent Director
  • 165.67K
  • Laurie B. Keating, J.D.
  • Independent Director
  • 179.88K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg